Learn More
Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus, human HPRT
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system.
3715.00 SEK - 16600.00 SEK
Specifications
Control Type | Positive Control |
---|---|
Delivery Type | Lentiviral |
Promoter | U6 |
Transfection Technique | Lentiviral transduction |
Species | Human |
Alert:
For Research Use Only. Not for use in diagnostic procedures.
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
15960353
|
Invitrogen™
A32056 |
100 μL |
3715.00 SEK
100µL |
Estimated Shipment: 03-05-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
15900383
|
Invitrogen™
A32829 |
1 mL |
16600.00 SEK
1mL |
Estimated Shipment: 03-05-2024 Log in to see stock. |
Please sign in to purchase this item. Need a web account? Register with us today! | ||||
Description
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system. The Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice.
The Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice.
Specifications
Positive Control | |
U6 | |
Human | |
LentiArray™ |
Lentiviral | |
Lentiviral transduction | |
CRISPR gene knockout | |
Dry Ice |
For Research Use Only. Not for use in diagnostic procedures.